Spironolactone for hypertension
Información
- DOI:
- https://doi.org/10.1002/14651858.CD008169Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 07 octubre 2009see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Protocol
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Hipertensión
- Copyright:
-
- Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
All three authors will be responsible for searching for trials, data extraction, data analyses, interpretation of data, and writing/editing of the final report.
Sources of support
Internal sources
-
Fraser Health Authority, Canada.
-
Northern Health Authority, Canada.
External sources
-
No sources of support supplied
Declarations of interest
Curt Fowkes has no perceived or actual conflicts of interest to declare.
Josh Batterink has no perceived or actual conflicts of interest to declare.
Aaron M Tejani has no perceived or actual conflicts of interest to declare for the past 6 years.
Acknowledgements
The authors would like to acknowledge the original authors of this protocol (Pillay A, Freemantle N, Griffin CC, Hill S, O' Reagan LL) who identified the topic and contributed extensive background work on the protocol.
The authors would also like to acknowledge the assistance provided by the Cochrane Hypertension Group.
Version history
Published | Title | Stage | Authors | Version |
2010 Aug 04 | Spironolactone for hypertension | Review | Josh Batterink, Sarah N Stabler, Aaron M Tejani, Curt T Fowkes | |
2009 Oct 07 | Spironolactone for hypertension | Protocol | Aaron M Tejani, Curt T Fowkes, Josh Batterink | |
Keywords
MeSH
Medical Subject Headings (MeSH) Keywords
Medical Subject Headings Check Words
Humans;